Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0036 CHF | -5.26% | +5.88% | +800.00% |
Mar. 28 | Swiss Exchange Regulator Drops Inquiry Into Kinarus Therapeutics | MT |
Feb. 06 | Kinarus Therapeutics Receives Swiss Court Approval for Revocation of Bankruptcy | MT |
1 day | -5.26% | ||
1 week | +5.88% | ||
Current month | -21.74% | ||
1 month | -5.26% | ||
3 months | +350.00% | ||
6 months | +500.00% | ||
Current year | +800.00% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Bausch
CEO | Chief Executive Officer | - | - |
Claudia Berger
CTO | Chief Tech/Sci/R&D Officer | - | - |
Matthew Wright
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Bausch
CEO | Chief Executive Officer | - | - |
Hari Kumar
CHM | Chairman | 69 | - |
Director/Board Member | 59 | - |
1st Jan change | Capi. | |
---|---|---|
+800.00% | 4.45M | |
-34.40% | 1.57B | |
+33.98% | 303M | |
-18.18% | 76.16M | |
-50.20% | 54.99M |
- Stock Market
- Equities
- CURE Stock